The 34th annual EAU congress from 15 to 19 March 2019 has gathered thousands of urologists from all over the world in Barcelona. As always, the large conference was filled with state of the art lectures, lively discussion, novel paradigms and practical sessions.
The huge amount of information produced at the meeting is a challenge to digest, even for those who attended the meeting. For this reason, we have written a congress report, covering a wide variety of topics. This report will guide you to some of the key messages delivered @EAU 2019 in Barcelona.
We hope this congress report issue of Medicom will help you to further increase your knowledge of urology and will help you to scientifically underbuilt your daily clinical practice.
Enjoy the congress report!
Kind regards,
Frank Van der Aa
Biography
Frank Van der Aa is adjunct head of clinic in the Department of Urology in the University Hospital Leuven and staff member of the National MS Center in Melsbroek, both in Belgium. In addition, he is lecturer of the Faculty of Medicine at the Catholic University of Leuven.
His special clinical interests are in neuro-urology, male and female incontinence and reconstructive urology. His major research interest include animal models of stress urinary incontinence and stem cell applications.
He is faculty member of the European School of Urology (ESU) since 2009, Editorial Board member of Neurourology and Neurodynamics since 2011, and member of the Video Congress Committee of the European Association of Urology (EAU) Scientific Congress Office since 2012. He is board member of the EAU section of Female and Functional Urology since 2012 and president of the working group functional urology of the Belgian Association of Urology (BAU).
Conflict of Interest: Nothing to disclose
Posted on
Previous Article
« Extrapolating data from clinical trials as we treat patients in real life Next Article
Live surgery bladder tumour resection »
« Extrapolating data from clinical trials as we treat patients in real life Next Article
Live surgery bladder tumour resection »
Table of Contents: EAU 2019
Featured articles
Prostate Cancer
Barentsz Trial – Bi-parametric MRI versus multi-parametric MRI
Enzalutamide plus ADT improves outcomes for metastatic hormone-sensitive prostate cancer
Prostate cancer active surveillance: Better patient risk stratification and use of imaging
The role of pelvic lymph node dissection in prostate cancer: Extended vs standard
When to use imaging and imaging-guided therapies
Radioguided surgery is the future?
Bladder Cancer
Largest safety study of its kind with atezolizumab in metastatic bladder cancer
Bladder cancer risk and early detection
Consensus treatment pathway for patients with limited pelvic lymph node involvement in otherwise localised bladder cancer
FGFR3 gene mutation: Favourable prognostic impact in bladder cancer
Bladder cancer in young patients
Spanish study directly links surgical volume with mortality in bladder cancer patients undergoing cystectomy
Updated interim results of phase 2 trial of pembrolizumab for high-risk NMIBC unresponsive to BCG
Robot-assisted radical cystectomy or open radical cystectomy?
Renal Transplantation and Renal Cell Carcinoma
Andrology
Microdissection testicular sperm extraction (microTESE)
Male infertility/Premature ejaculation
Testosterone replacement therapy: Safe and maybe even protective
Focus on treatment of erectile dysfunction and Peyronie’s disease
Penile prosthesis implantation
Functional Urology
Decision aids are too difficult for patients
Lower Urinary Tract Symptoms
The Urodynamics for Prostate Surgery Trial
Minimally invasive surgical techniques must compete against pharmacotherapy in benign prostate hyperplasia (BPH)
Related Articles
January 25, 2023
Looking Forward to 2023: Anticipated Medical Innovations
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com